LAWRENCE – A seasoned professional with successful experience in private business, state government and higher education will join the University of Kansas Feb. 1 as the new director of its bicampus Center for Technology Commercialization (KUCTC). It is a key hire for KU as it seeks to translate more faculty research into marketplace solutions and drive economic development in Kansas.

July 22, 2013

LAWRENCE — There’s no room left at the inn. Or in this case, the incubator. Global drug discovery company Ligand Pharmaceuticals Incorporated has signed a lease with the Bioscience & Technology Business Center at the University of Kansas (BTBC at KU) Main Facility to occupy the building’s last remaining space. The move brings the BTBC Main Facility to 100 percent occupancy a year-and-a-half after it opened its doors in summer 2010.

July 22, 2013

Good afternoon. It’s a pleasure to be here to deliver today’s co-host keynote address. I’m especially honored to share the stage with President Proenza, who as you just heard, is taking the University of Akron in an exciting direction with regard to research commercialization and tech transfer. Like many universities represented here today, Akron is an organization we can emulate and learn from.

July 22, 2013

LAWRENCE – University of Kansas research has led to the creation of a new startup company that will develop online curriculum for health care professionals involved in managing the care of cancer survivors.

July 22, 2013

Dear Colleagues, As the state’s flagship university, the University of Kansas has a responsibility to contribute to the health, vitality and prosperity of our state. Included in that mission is encouraging the commercialization of KU discoveries. As part of Bold Aspirations, for the first time both the number of startup companies we create and the amount of technology we bring to market are formal metrics for how we’ll judge ourselves.

July 22, 2013

LAWRENCE – University of Kansas researchers have earned three of 31 presentation slots at one of the nation’s most exclusive venture capital events.

July 22, 2013

This spring, Associate Professor of Business Sanjay Mishra and the President of the KU Center for Technology Commercialization Julie Goonewardene introduced a new business course at the University of Kansas. Mishra is a faculty member at CReSIS and part of the CReSIS Knowledge Transfer team.

 

July 22, 2013

Business Center at the University of Kansas Medical Center (BTBC at KUMC) has secured its fifth tenant.

 

July 22, 2013

Austin, TX, June 12, 2012 – Savara Pharmaceuticals, an emerging specialty pharmaceutical company developing innovative pulmonary drugs for the treatment of serious and life-threatening conditions, today announced positive top-line data from its AeroVanc Phase I clinical study in patients with cystic fibrosis (CF).

July 22, 2013

LAWRENCE — A pharmaceutical company based on University of Kansas technology has established a partnership with an India-based drug formulation company.

July 22, 2013

Pages


Events
KU Today